Tag: CX 2024
Long-term IN.PACT AV data show there is “definitely a place” for...
Matteo Tozzi (Varese, Italy) and Kate Steiner (Stevenage, UK) sat down with Vascular News at this year’s Charing Cross (CX) International Symposium (23–25 April,...
Renal Interventions’ top 10 stories of June 2024
The month of June gave us insight into the future of standard-of-care, updates from meetings, and what can be achieved “with a bit of...
IN.PACT AV Access five-year results strengthen physicians’ conviction on applying DCB...
Alexander Mallios (Paris, France) and Andrew Holden (Auckland, New Zealand; one of the co-chairs of the Charing Cross Symposium) share their views on...
Angioplasty with novel, easy-to-use, bladed Flex Vessel Prep system “could replace...
Robert Shahverdyan (Hamburg, Germany) encourages interventionalists to try the new Flex Vessel Prep system (VentureMed) to experience the benefits that arrive in the wake...
Renal Interventions’ top 10 stories of May 2024
In May, we saw revolutionary new devices, trials that show promise for the future of chronic kidney disease (CKD), and the role of medication...
Renal Interventions 12
Highlights
New trial evidence regarding the use of semaglutide for patients with type 2 diabetes and chronic kidney disease from the 61st European Renal...
Five-year data finds for IN.PACT AV DCB over plain balloon angioplasty
During the Vascular Access Masterclass session examining the question ‘We have new technology, but do we need it?’ at this year’s Charing Cross (CX)...
Is renal denervation out of retirement?
“It’s rare to see a single trial kill something that was greeted with enthusiasm, so the question is why is renal denervation alive again?...
Keeping it real: Vascular access cases and solutions from across the...
During this year’s Charing Cross (CX) International Symposium (23–25th April, London, UK), the first day saw two separate sessions titled ‘Real Cases, Real Problems’,...
VasQ: The next standard-of-care innovation
This advertorial is sponsored by Laminate Medical Technologies
At the 2024 Charing Cross (CX) International Symposium (23–25 April, London, UK), the Vascular Access Masterclass Controversies...
CX 2024 debates success of the “endoAVF experiment”
The Vascular Access Controversies Masterclass at this year’s Charing Cross (CX) International Symposium (23–25 April, London, UK) was the setting for a Great Debate...
CX YourAnastomosis Vascular Access Competition winner announced
At the recent Charing Cross (CX) International Symposium (23–25 April, London, UK), a ground-breaking initiative emerged, focusing on enhancing vascular access anastomosis skills. Through...
Access monitoring and vessel management spotlighted in Renal Interventions Controversies session
During the Renal Interventions Controversies programme that took place on the first day of the recent Charing Cross (CX) International Symposium (23–25 April, London,...
Renal Interventions’ top 10 stories of April 2024
April was a month of world-firsts, new collaborations, and useful data, with a team from Massachusetts General Hospital (Boston, USA) performing the world’s first...
“We know which DCB to use”—but many other questions remain in...
A first-time presentation of five-year data from the IN.PACT AV Access study evaluating the IN.PACT AV (Medtronic) drug-coated balloon (DCB) today led principal investigator...
CX 2024 promises “not only the complex, the new, the innovative,...
CX Executive Board members Nicholas Inston (Birmingham, United Kingdom) and Kate Steiner (Stevenage, United Kingdom) discuss some of the highlights of this year’s CX...
Renal Interventions 11 – EU
Highlights
New trial evidence about the benefits of preoperative forearm exercises for vein diameter from Koen van der Bogt (Leiden, The Netherlands)
The importance...
Renal Interventions 11 – US
Highlights
New trial evidence about the benefits of preoperative forearm exercises for vein diameter from Koen van der Bogt (Leiden, The Netherlands)
The importance...